Medicare Enrolled

Dr. Roland Belluscio, MD

Cardiovascular Disease · Red Bank, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
280 HIGHWAY 35, Red Bank, NJ 07701
7329775509
In practice since 2006 (20 years)
NPI: 1477523314 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Belluscio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Belluscio? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Belluscio

Dr. Roland Belluscio is a cardiovascular disease specialist in Red Bank, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Belluscio performed 3,628 Medicare services across 1,960 unique beneficiaries.

Between the years covered by Open Payments, Dr. Belluscio received a total of $5,411 from 33 pharmaceutical and/or device companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Belluscio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 32% volume in NJ $5,411 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,628
Medicare services
Top 32% in NJ for cardiovascular disease
1,960
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~181 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,219 $96 $464
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
1,172 $11 $75
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
267 $66 $408
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
209 $53 $273
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
117 $99 $590
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
116 $142 $1,146
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
98 $124 $709
Remote monitoring of implantable heart rhythm device
Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days.
97 $30 $200
Remote pacemaker/defibrillator monitoring, 90 days
Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check.
92 $18 $119
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
87 $69 $318
Remote pacemaker monitoring, 90 days
Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart.
64 $22 $145
Smoking cessation counseling, more than 10 minutes
Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes.
22 $29 $158
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
20 $10 $89
Continuous ECG monitoring, up to 30 days
Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results.
17 $20 $100
Pacemaker system evaluation
Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems.
17 $50 $164
EKG interpretation and report
A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report.
14 $7 $36
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.5% high complexity
0.0% medium
89.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,411
Total received (2018-2024)
Avg $773/year across 7 years
Top 35% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
334
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,411 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$431
2023
$424
2022
$509
2021
$921
2020
$579
2019
$961
2018
$1,585

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$142
Novo Nordisk Inc
$60
Janssen Pharmaceuticals, Inc
$34
Esperion Therapeutics, Inc.
$33
PFIZER INC.
$31
Amgen Inc.
$29
AGEPHA Pharma FZ LLC
$21
Boston Scientific Corporation
$20
Azurity Pharmaceuticals, Inc.
$17
Lilly USA, LLC
$16
Novartis Pharmaceuticals Corporation
$14
Kestra Medical Technology Services, Inc.
$13
Top 3 companies account for 54.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,309
Abbott Laboratories
$517
Amgen Inc.
$459
Janssen Pharmaceuticals, Inc
$454
Amarin Pharma Inc.
$363
E.R. Squibb & Sons, L.L.C.
$284
Novo Nordisk Inc
$250
Kowa Pharmaceuticals America, Inc.
$203
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
PFIZER INC.
$127
Esperion Therapeutics, Inc.
$125
Bayer HealthCare Pharmaceuticals Inc.
$115
Medtronic Vascular, Inc.
$110
Boston Scientific Corporation
$109
Regeneron Healthcare Solutions, Inc.
$104
Gilead Sciences, Inc.
$97
BOSTON SCIENTIFIC CORPORATION
$83
SANOFI-AVENTIS U.S. LLC
$69
Lilly USA, LLC
$67
Novartis Pharmaceuticals Corporation
$56
GlaxoSmithKline, LLC.
$56
ARALEZ PHARMACEUTICALS US INC.
$53
Bayer Healthcare Pharmaceuticals Inc.
$52
Allergan Inc.
$41
ARBOR PHARMACEUTICALS, INC.
$29
AGEPHA Pharma FZ LLC
$21
Azurity Pharmaceuticals, Inc.
$17
G Medical Diagnostic Services, Inc.
$15
Merck Sharp & Dohme Corporation
$14
Kestra Medical Technology Services, Inc.
$13
iRhythm Technologies, Inc.
$13
Kiniksa Pharmaceuticals, Ltd.
$13
Relypsa, Inc.
$12
Top 3 companies account for 42.2% of all-time payments
Associated products mentioned in payments ›
Assure WCD · Assurity Pacemaker · Azure · BRILINTA · BYSTOLIC · Bidil · CAMZYOS · CHANTIX · Cardiac Monitoring Suite · Confirm Rx · Corlanor · EDARBI · ELIQUIS · Edarbyclor · FARXIGA · General - Therapies · ICDs · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LODOCO · LYNPARZA · Livalo · Mitra Clip system · NEXLETOL · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Quadra Assura CRT Defibrillator · Repatha · Rybelsus · TRELEGY ELLIPTA · TRULICITY · Tresiba · VIGILANT · VYNDAQEL · Vascepa · Veltassa · Victoza · WATCHMAN · WATCHMAN FLX · Wegovy · XARELTO · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease specialist in Red Bank?
Compare cardiologists in the Red Bank area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
412
Per 100K population
64.0
County median income
$122,727
Nearest hospital
RIVERVIEW MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Belluscio is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Belluscio experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Belluscio performed 1,219 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Belluscio receive payments from pharmaceutical companies?
Yes. Dr. Belluscio received a total of $5,411 from 33 companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Belluscio's costs compare to other cardiologists in Red Bank?
Dr. Belluscio's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Belluscio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →